Page 615 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 26 Tumors of the Endocrine System 593

314. Chun R, Garrett LD, Sargeant J, et al.: Predictors of response to 335. Kallet AJ, Richter KP, Feldman EC, et al.: Primary hyperpara-
radioiodine therapy in hyperthyroid cats, Vet Radiol Ultrasound thyroidism in cats: seven cases (1984-1989), J Am Vet Med Assoc
43:587–591, 2002. 199:1767–1771, 1991.
VetBooks.ir 315. Meric SM, Rubin SI: Serum thyroxine concentrations following 336. Barber PJ: Disorders of the parathyroid glands, J Feline Med Surg
6:259–269, 2004.
fixed-dose radioactive iodine treatment in hyperthyroid cats: 62
cases (1986-1989), J Am Vet Med Assoc 197:621–623, 1990.
316. Lucy JM, Peterson ME, Randolph JF, et al.: Efficacy of low-dose 337. Feldman EC, Hoar B, Pollard R, et al.: Pretreatment clinical and
laboratory findings in dogs with primary hyperparathyroidism: 210
(2 millicurie) versus standard-dose (4 millicurie) radioiodine treat- cases (1987-2004), J Am Vet Med Assoc 227:756–761, 2005.
ment for cats with mild-to-moderate hyperthyroidism, J Vet Intern 338. Gear RN, Neiger R, Skelly BJ, et al.: Primary hyperparathyroid-
Med 31:326–334, 2017. ism in 29 dogs: diagnosis, treatment, outcome and associated renal
317. Vagney M, Desquilbet L, Reyes-Gomez E, et al.: Survival times failure, J Small Anim Pract 46:10–16, 2005.
for cats with hyperthyroidism treated with a 3.35 mCi iodine-131 339. Rasor L, Pollard R, Feldman EC: Retrospective evaluation of three
dose: a retrospective study of 96 cases, J Feline Med Surg 20:528– treatment methods for primary hyperparathyroidism in dogs, J Am
534, 2018. Anim Hosp Assoc 43:70–77, 2007.
318. Peterson ME: Radioiodine treatment of hyperthyroidism, Clin Tech 340. Feldman EC: Hypercalcemia and primary hyperparathyroidism. In
Small Anim Pract 21:34–39, 2006. Feldman EC, Nelson RW, Reusch CE, et al.: Canine and feline
319. Boag AK, Neiger R, Slater L, et al.: Changes in the glomerular endocrinology, ed 4, St. Louis, 2015, Elsevier, pp 579–624.
filtration rate of 27 cats with hyperthyroidism after treatment with 341. Skelly BJ: Primary hyperparathyroidism. In Ettinger SJ, Feldman
radioactive iodine, Vet Rec 161:711–715, 2007. EC, Cote E, editors: Textbook of veterinary internal medicine, ed 8,
320. Nykamp SG, Dykes NL, Zarfoss MK, et al.: Association of the risk St. Louis, 2017, Elsevier, pp 1715–1727.
of development of hypothyroidism after iodine 131 treatment with 342. Cavana P, Vittone V, Capucchio MT, et al.: Parathyroid adeno-
the pretreatment pattern of sodium pertechnetate Tc 99m uptake carcinoma in a nephropathic Persian cat, J Feline Med Surg 8:340–
in the thyroid gland in cats with hyperthyroidism: 165 cases (1990- 344, 2006.
2002), J Am Vet Med Assoc 226:1671–1675, 2005. 343. Skelly BJ, Franklin RJ: Mutations in genes causing human familial
321. Williams TL, Elliott J, Syme HM: Association of iatrogenic hypo- isolated hyperparathyroidism do not account for hyperparathyroid-
thyroidism with azotemia and reduced survival time in cats treated ism in Keeshond dogs, Vet J 174:652–654, 2007.
for hyperthyroidism, J Vet Intern Med 24:1086–1092, 2010. 344. Sawyer ES, Northrup NC, Schmiedt CW, et al.: Outcome of 19
322. Milner RJ, Channell CD, Levy JK, et al.: Survival times for cats with dogs with parathyroid carcinoma after surgical excision, Vet Comp
hyperthyroidism treated with iodine 131, methimazole, or both: Oncol 10:57–64, 2012.
167 cases (1996-2003), J Am Vet Med Assoc 228:559–563, 2006. 345. Faucher MR, Freiche V, Bongrand Y, et al.: Primary hyperpara-
323. Goldstein RE, Long C, Swift NC, et al.: Percutaneous ethanol thyroidism caused by a parathyroid carcinoma in a 16-year-old
injection for treatment of unilateral hyperplastic thyroid nodules in male neutered cat with concurrent chronic kidney disease, Vet Q
cats, J Am Vet Med Assoc 218:1298–1302, 2001. 34:37–40, 2014.
324. Wells AL, Long CD, Hornof WJ, et al.: Use of percutaneous etha- 346. Kishi EN, Holmes SP, Abbott JR, et al.: Functional metastatic
nol injection for treatment of bilateral hyperplastic thyroid nodules parathyroid adenocarcinoma in a dog, Can Vet J 55:383–388,
in cats, J Am Vet Med Assoc 218:1293–1297, 2001. 2014.
325. Mallery KF, Pollard RE, Nelson RW, et al.: Percutaneous ultra- 347. Parker VJ, Gilor C, Chew DJ: Feline hyperparathyroidism: patho-
sound-guided radiofrequency heat ablation for treatment of hyper- physiology, diagnosis and treatment of primary and secondary dis-
thyroidism in cats, J Am Vet Med Assoc 223:1602–1607, 2003. ease, J Feline Med Surg 17:427–439, 2015.
326. Vaske HH, Schermerhorn T, Grauer GF: Effects of feline hyper- 348. Goldstein RE, Atwater DZ, Cazolli DM, et al.: Inheritance, mode
thyroidism on kidney function: a review, J Feline Med Surg 18:55– of inheritance, and candidate genes for primary hyperparathyroid-
59, 2016. ism in Keeshonden, J Vet Intern Med 21:199–203, 2007.
327. Graves TK, Olivier NB, Nachreiner RF, et al.: Changes in renal 349. Schenck PA, Chew DJ: Prediction of serum ionized calcium con-
function associated with treatment of hyperthyroidism in cats, Am centration by use of serum total calcium concentration in dogs, Am
J Vet Res 55:1745–1749, 1994. J Vet Res 66:1330–1336, 2005.
328. Becker TJ, Graves TK, Kruger JM, et al.: Effects of methimazole on 350. Schenck PA, Chew DJ: Prediction of serum ionized calcium con-
renal function in cats with hyperthyroidism, J Am Anim Hosp Assoc centration by serum total calcium measurement in cats, Can J Vet
36:215–223, 2000. Res 74:209–213, 2010.
329. DiBartola SP, Broome MR, Stein BS, et al.: Effect of treatment 351. Savary KC, Price GS, Vaden SL: Hypercalcemia in cats: a retrospec-
of hyperthyroidism on renal function in cats, J Am Vet Med Assoc tive study of 71 cases (1991-1997), J Vet Intern Med 14:184–189,
208:875–878, 1996. 2000.
330. Adams WH, Daniel GB, Legendre AM, et al.: Changes in renal 352. Messinger JS, Windham WR, Ward CR: Ionized hypercalcemia in
function in cats following treatment of hyperthyroidism using dogs: a retrospective study of 109 cases (1998-2003), J Vet Intern
131I, Vet Radiol Ultrasound 38:231–238, 1997. Med 23:514–519, 2009.
331. van Hoek I, Lefebvre HP, Peremans K, et al.: Short- and long-term 353. Feldman EC, Wisner ER, Nelson RW, et al.: Comparison of results
follow-up of glomerular and tubular renal markers of kidney func- of hormonal analysis of samples obtained from selected venous sites
tion in hyperthyroid cats after treatment with radioiodine, Domest versus cervical ultrasonography for localizing parathyroid masses in
Anim Endocrinol 36:45–56, 2009. dogs, J Am Vet Med Assoc 211:54–56, 1997.
332. Peterson ME, Varela FV, Rishniw M, et al.: Evaluation of serum 354. Sueda MT, Stefanacci JD: Ultrasound evaluation of the para-
symmetric dimethylarginine concentration as a marker for masked thyroid glands in two hypercalcemic cats, Vet Radiol Ultrasound
chronic kidney disease in cats with hyperthyroidism, J Vet Intern 41:448–451, 2000.
Med 32:295–304, 2018. 355. Liles SR, Linder KE, Cain B, et al.: Ultrasonography of histologi-
333. Riensche MR, Graves TK, Schaeffer DJ: An investigation of predic- cally normal parathyroid glands and thyroid lobules in normocal-
tors of renal insufficiency following treatment of hyperthyroidism cemic dogs, Vet Radiol Ultrasound 51:447–452, 2010.
in cats, J Feline Med Surg 10:160–166, 2008. 356. Matwichuk CL, Taylor SM, Daniel GB, et al.: Double-phase para-
334. Williams TL, Peak KJ, Brodbelt D, et al.: Survival and the develop- thyroid scintigraphy in dogs using technetium-99M-sestamibi, Vet
ment of azotemia after treatment of hyperthyroid cats, J Vet Intern Radiol Ultrasound 41:461–469, 2000.
Med 24:863–869, 2010.